Amifloxacin

DB20048ExperimentalSmall molecule

Amifloxacin is a small molecule drug. The usage of the INN stem '-oxacin' in the name indicates that Amifloxacin is a nalidixic acid derivative antibacterial. Amifloxacin has a monoisotopic molecular...

Formula / weight: C₁₆H₁₉FN₄O₃ · 334.351 g/mol (avg)
Code names: WIN-49,375

Resolves to

Compound

UNII5TU5227KYQCAS86393-37-5ChEMBLCHEMBL6231ChEBI169231

Structure

InChIKeyRUXPNBWPIRDVTH-UHFFFAOYSA-NSMILESCNN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCN(C)CC1

Targets

P11388TOP2AQ02880TOP2B

What you can answer from here — as of September 19, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Amifloxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account